Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
GERN
#2376
Geron Corp
1.7
7
USD
+2.31%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
+2.31%
Mudança mensal
+11.32%
Mudança em 6 meses
+39.37%
Mudança anual
+35.11%
Fechamento anterior
1.7
3
Abrir
1.7
7
Bid
Ask
Mínimo
1.7
7
High
1.7
7
Volume
71
Mercados
Ações
Cuidados de saúde
GERN
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
318.53 M
323.73 M
508.72 M
546.06 M
636.9 M
640.54 M
—
Valuation ratios
Enterprise value
526.25 M
414.18 M
1.2 B
1.14 B
2.3 B
888.95 M
3.8 B
Price to earnings ratio
—
—
-6.49
-6.69
-13.11
-10.15
-39.99
Price to sales ratio
—
—
1 533.36
5 152.66
-1 339.75
—
—
Price to cash flow ratio
—
—
-7.17
-7.28
-10.46
-7.93
-25.05
Price to book ratio
—
—
11.42
4.93
8.16
3.9
6.51
Enterprise value to EBITDA ratio
-6.55
-3.22
-8.42
-5.38
-8.2
-2.97
—
Profitability ratios
Return on assets %
-0.28
-0.51
-0.74
-0.47
-0.29
-0.15
-0.15
Return on equity %
-0.36
-0.92
-1.77
-0.74
-0.62
-0.37
-0.34
Return on invested capital %
-370.38
-500.89
-861.79
-727.02
-533.33
-95.12
—
Gross margin %
100
100
100
100
100
—
—
Operating margin %
-30.4 K
-8 183.7
-23.25 K
-81.83 K
10.18 K
—
—
EBITDA margin %
-29.94 K
-8 017.37
-23.19 K
-86.08 K
15.54 K
—
—
Net margin %
-29.89 K
-8 335.39
-23.81 K
-77.69 K
10.23 K
—
—
Liquidity ratios
Quick ratio
—
—
—
—
5.12
3.62
22.25
Current ratio
6.46
4.11
2.35
3.16
5.56
4.66
26.35
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0.01
0
0
-0
0
—
Solvency ratios
Debt to assets ratio
0.11
0.24
0.18
0.1
0.2
0.21
0.86
Debt to equity ratio
0.14
0.43
0.42
0.15
0.43
0.54
1.94
Long term debt to total assets ratio
0.09
0.22
0.16
0.09
0.2
0.21
0.85
Long term debt to total equity ratio
0.11
0.39
0.38
0.14
0.42
0.53
1.91
Per share metrics
Operating cash flow per share
—
—
-0.33
-0.29
-0.34
-0.17
-0.17
EBIT per share
—
—
-0.36
-0.34
-0.39
-0.38
—
EBITDA per share
—
—
-0.36
-0.36
-0.41
-0.39
—
Total debt per share
—
—
0.09
0.07
0.19
0.18
0.73
Cash per share
—
—
0.45
0.58
0.63
0.12
0.48
Net current asset value per share
—
—
0.47
0.6
0.76
0.78
3.07
Tangible book value per share
—
—
0.21
0.43
0.43
0.34
1.5
Working capital per share
—
—
0.27
0.41
0.62
0.61
2.58
Book value per share
—
—
0.21
0.43
0.43
0.34
1.5
Geron Corporation
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.
Notícias
Geron nomeia Patricia S. Andrews e Constantine Chinoporos para o conselho de administração
Geron na Conferência de Saúde da Barclays: crescimento estratégico e planos futuros
Geron at Barclays Healthcare Conference: Strategic Growth and Future Plans
Geron Corporation (GERN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Can Reblozyl Stabilize BMY's Top Line Amid Legacy Drugs Decline?
Geron na TD Cowen: crescimento estratégico e expansão de mercado
Geron at TD Cowen: Strategic Growth and Market Expansion
Geron: Why I'm Doubling Down On My 'Sell' Rating After Q4 Earnings (NASDAQ:GERN)
Geron Corporation (GERN) Q4 2025 Earnings Call Transcript
Geron (GERN) Reports Q4 Loss, Misses Revenue Estimates
Lucro da Geron veio abaixo das projeções por $0,02; receita menor do que estimativas
Geron earnings missed by $0.02, revenue fell short of estimates